Article
Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors.
Human pathology - 1 Sept 2026
Bhardwaj Swati, Amaral Adrianna, Dairo Oluwademilade, Akbari Amir, Pivovarcikova Kristyna, Williamson Sean R, Antic Tatjana, Argani Pedram, Asrani Kaushal, Lotan Tamara L
Abstract excerpt
A widening spectrum of renal tumors is driven by alterations in mTOR pathway genes. We examined the relationship between the specific underlying genomic driver mutation, mTOR signaling activation and tumor histologic subtype among mTOR pathway-altered tumors. mTOR pathway activation was assessed by quantifying expression of GPNMB in 16 cases of eosinophilic vacuolated tumor (EVT), 13 cases of low grade oncocytic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
